<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Trigeminal Neuralgia: Clinical Quick-Scan</title>
    <!-- Using FontAwesome for Icons -->
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    
    <style>
        :root {
            /* Color Palette */
            --color-danger: #d32f2f;      /* Red Flags / Contraindications */
            --color-danger-bg: #ffebee;
            --color-success: #2e7d32;    /* Safe Actions / First-line */
            --color-success-bg: #e8f5e9;
            --color-primary: #1565c0;    /* General Info / Diagnosis */
            --color-primary-bg: #e3f2fd;
            --color-warning: #f57f17;    /* Cautions / Adverse Effects */
            --color-warning-bg: #fffde7;
            --color-text: #263238;
            --color-text-muted: #546e7a;
            --color-bg: #f5f7fa;
            --color-card-bg: #ffffff;
            
            /* Spacing & Layout */
            --spacing-sm: 0.5rem;
            --spacing-md: 1rem;
            --spacing-lg: 1.5rem;
            --radius: 8px;
            --shadow: 0 4px 6px rgba(0,0,0,0.1);
            --shadow-hover: 0 10px 15px rgba(0,0,0,0.15);
        }

        * {
            box-sizing: border-box;
            margin: 0;
            padding: 0;
        }

        body {
            font-family: 'Segoe UI', Roboto, Helvetica, Arial, sans-serif;
            line-height: 1.5;
            color: var(--color-text);
            background-color: var(--color-bg);
            padding-bottom: 2rem;
        }

        /* --- Header --- */
        header {
            background-color: var(--color-primary);
            color: white;
            padding: var(--spacing-lg) var(--spacing-md);
            box-shadow: var(--shadow);
        }

        .header-content {
            max-width: 1200px;
            margin: 0 auto;
            display: flex;
            justify-content: space-between;
            align-items: center;
            flex-wrap: wrap;
        }

        .header-title h1 {
            font-size: 1.8rem;
            font-weight: 700;
            margin-bottom: var(--spacing-sm);
        }

        .header-meta {
            font-size: 0.9rem;
            opacity: 0.9;
            display: flex;
            gap: var(--spacing-md);
        }

        .badge {
            background: rgba(255,255,255,0.2);
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
        }

        /* --- Main Layout --- */
        main {
            max-width: 1200px;
            margin: var(--spacing-lg) auto;
            padding: 0 var(--spacing-md);
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: var(--spacing-lg);
        }

        .full-width {
            grid-column: 1 / -1;
        }

        /* --- Cards & Sections --- */
        .card {
            background: var(--color-card-bg);
            border-radius: var(--radius);
            box-shadow: var(--shadow);
            padding: var(--spacing-lg);
            margin-bottom: var(--spacing-lg);
            border-left: 5px solid transparent;
            transition: transform 0.2s ease, box-shadow 0.2s ease;
            position: relative;
            overflow: hidden;
        }

        .card:hover {
            transform: translateY(-3px);
            box-shadow: var(--shadow-hover);
        }

        .card-header {
            display: flex;
            align-items: center;
            margin-bottom: var(--spacing-md);
            border-bottom: 1px solid #eee;
            padding-bottom: var(--spacing-sm);
        }

        .card-header i {
            margin-right: var(--spacing-sm);
            font-size: 1.4rem;
        }

        .card-header h2 {
            font-size: 1.25rem;
            font-weight: 600;
        }

        /* --- Color Variants --- */
        .danger-zone {
            border-left-color: var(--color-danger);
        }
        .danger-zone .card-header { color: var(--color-danger); }

        .safe-zone {
            border-left-color: var(--color-success);
        }
        .safe-zone .card-header { color: var(--color-success); }

        .info-zone {
            border-left-color: var(--color-primary);
        }
        .info-zone .card-header { color: var(--color-primary); }

        .warning-zone {
            border-left-color: var(--color-warning);
        }
        .warning-zone .card-header { color: var(--color-warning); }

        /* --- Content Lists & Tables --- */
        ul.check-list {
            list-style: none;
        }

        ul.check-list li {
            position: relative;
            padding-left: 1.5rem;
            margin-bottom: var(--spacing-sm);
        }

        ul.check-list li::before {
            content: '\f00c'; /* FontAwesome Check */
            font-family: 'Font Awesome 6 Free';
            font-weight: 900;
            position: absolute;
            left: 0;
            color: var(--color-success);
        }

        ul.cross-list li::before {
            content: '\f00d'; /* FontAwesome X */
            color: var(--color-danger);
        }

        /* --- Red Flags Highlight --- */
        .red-flag-alert {
            background-color: var(--color-danger-bg);
            border: 1px solid var(--color-danger);
            color: #b71c1c;
            padding: var(--spacing-md);
            border-radius: var(--radius);
            font-weight: 600;
            margin-bottom: var(--spacing-md);
            display: flex;
            align-items: center;
            gap: var(--spacing-sm);
            animation: pulse 3s infinite;
        }

        @keyframes pulse {
            0% { box-shadow: 0 0 0 0 rgba(211, 47, 47, 0.4); }
            70% { box-shadow: 0 0 0 10px rgba(211, 47, 47, 0); }
            100% { box-shadow: 0 0 0 0 rgba(211, 47, 47, 0); }
        }

        /* --- Dosing Timeline --- */
        .dosing-step {
            display: flex;
            gap: var(--spacing-md);
            margin-bottom: var(--spacing-md);
            align-items: flex-start;
        }

        .step-number {
            background: var(--color-primary);
            color: white;
            width: 30px;
            height: 30px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: bold;
            flex-shrink: 0;
        }

        .step-content h4 {
            margin-bottom: 2px;
            color: var(--color-text);
        }
        .step-content p {
            font-size: 0.9rem;
            color: var(--color-text-muted);
            margin: 0;
        }

        /* --- Safety Grid --- */
        .safety-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: var(--spacing-md);
        }

        .safety-item {
            padding: var(--spacing-sm);
            background: var(--color-bg);
            border-radius: 4px;
            font-size: 0.9rem;
        }
        
        .safety-item i {
            margin-right: 5px;
        }

        /* --- Interactive Toggle --- */
        .details-toggle {
            cursor: pointer;
            color: var(--color-primary);
            font-size: 0.9rem;
            text-decoration: underline;
            margin-top: var(--spacing-sm);
            display: inline-block;
        }

        .collapsible-content {
            display: none;
            margin-top: var(--spacing-md);
            padding-top: var(--spacing-md);
            border-top: 1px dashed #ccc;
        }
        
        .collapsible-content.active {
            display: block;
            animation: fadeIn 0.3s;
        }

        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }

        /* --- Responsive --- */
        @media (max-width: 768px) {
            main {
                grid-template-columns: 1fr;
            }
            .header-content {
                flex-direction: column;
                align-items: flex-start;
                gap: 10px;
            }
            .safety-grid {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>
<body>

<header>
    <div class="header-content">
        <div class="header-title">
            <h1>Trigeminal Neuralgia</h1>
            <div class="header-meta">
                <span class="badge"><i class="fas fa-user-md"></i> Primary Care / Adults 18+</span>
                <span class="badge"><i class="fas fa-calendar"></i> Updated: Jan 2024</span>
            </div>
        </div>
        <div style="font-size: 0.85rem; max-width: 400px; background: rgba(0,0,0,0.2); padding: 10px; border-radius: 6px;">
            <i class="fas fa-exclamation-circle"></i> <strong>Exclusions:</strong> Pregnancy, breastfeeding, other facial neuropathic pain (refer to specific CKS topics).
        </div>
    </div>
</header>

<main>

    <!-- SECTION 1: DIAGNOSIS -->
    <section class="full-width">
        <div class="card info-zone">
            <div class="card-header">
                <i class="fas fa-stethoscope"></i>
                <h2>Diagnosis Checklist</h2>
            </div>
            
            <div style="display: grid; grid-template-columns: repeat(auto-fit, minmax(300px, 1fr)); gap: 2rem;">
                
                <!-- Classic Signs -->
                <div>
                    <h3 style="margin-bottom: 1rem; color: var(--color-primary);"><i class="fas fa-check-circle"></i> Classic Presentation</h3>
                    <ul class="check-list">
                        <li><strong>Severe facial pain:</strong> Electric shock-like, sharp, shooting.</li>
                        <li><strong>Unilateral:</strong> Usually maxillary (cheek) or mandibular (jaw) branches. Ophthalmic rare.</li>
                        <li><strong>Short duration:</strong> Seconds to 2 minutes. Sudden stop.</li>
                        <li><strong>Triggers:</strong> Light touch, eating, talking, cold wind, brushing teeth.</li>
                        <li><strong>Remission:</strong> Periods of no pain (weeks/months) initially.</li>
                    </ul>
                </div>

                <!-- Red Flags -->
                <div class="danger-zone" style="background-color: #fff5f5; border-radius: 8px; padding: 1rem;">
                    <div class="red-flag-alert">
                        <i class="fas fa-ambulance"></i> Serious Red Flags (Refer/Urgent)
                    </div>
                    <ul class="cross-list">
                        <li>Age of onset <strong>under 40 years</strong>.</li>
                        <li>Bilateral pain or pain only in the <strong>ophthalmic division</strong> (eye/forehead).</li>
                        <li><strong>Sensory changes</strong> (numbness/loss).</li>
                        <li>Optic neuritis or deafness.</li>
                        <li>History of <strong>Multiple Sclerosis</strong> or lesions.</li>
                    </ul>
                </div>

            </div>
        </div>
    </section>

    <!-- SECTION 2: MANAGEMENT -->
    <section class="safe-zone" style="grid-column: 1 / -1;">
        <div class="card safe-zone" style="border-left: 5px solid var(--color-success);">
            <div class="card-header">
                <i class="fas fa-prescription-bottle-medical"></i>
                <h2>Primary Management: Carbamazepine</h2>
            </div>
            
            <div style="display: flex; flex-direction: column; gap: 1.5rem;">
                
                <!-- Step 1 -->
                <div class="dosing-step">
                    <div class="step-number">1</div>
                    <div class="step-content">
                        <h4>Initial Dose</h4>
                        <p>Start <strong>100 mg</strong> once or twice daily.</p>
                    </div>
                </div>

                <!-- Step 2 -->
                <div class="dosing-step">
                    <div class="step-number">2</div>
                    <div class="step-content">
                        <h4>Titration</h4>
                        <p>Increase by steps of <strong>100–200 mg</strong> every <strong>2 weeks</strong> until pain is relieved.</p>
                    </div>
                </div>

                <!-- Step 3 -->
                <div class="dosing-step">
                    <div class="step-number">3</div>
                    <div class="step-content">
                        <h4>Maintenance</h4>
                        <p>Usually <strong>200 mg three or four times a day</strong>. Modify-release: 600–800 mg in 2 divided doses.</p>
                    </div>
                </div>

                <!-- Step 4 -->
                <div class="dosing-step">
                    <div class="step-number" style="background: var(--color-text);">MAX</div>
                    <div class="step-content">
                        <h4>Maximum Dose</h4>
                        <p><strong>1600 mg</strong> daily.</p>
                    </div>
                </div>

            </div>

            <div style="margin-top: 1.5rem; padding-top: 1rem; border-top: 1px solid #eee; display: flex; gap: 1rem; align-items: center;">
                <i class="fas fa-user-clock" style="font-size: 1.5rem; color: var(--color-primary);"></i>
                <div>
                    <strong>Follow-up:</strong> Arrange early review to assess titration and tolerability.<br>
                    <em>Once pain is in remission, gradually reduce to lowest maintenance level or stop.</em>
                </div>
            </div>
        </div>
    </section>

    <!-- SECTION 3: SPECIALIST REFERRAL -->
    <section class="info-zone">
        <div class="card info-zone">
            <div class="card-header">
                <i class="fas fa-hospital-user"></i>
                <h2>When to Refer</h2>
            </div>
            <ul class="check-list">
                <li>Severe pain not controlled by Carbamazepine.</li>
                <li>Carbamazepine is contraindicated or not tolerated.</li>
                <li>Pain significantly limits daily activities (eating, sleeping).</li>
                <li>Atypical features (burning background pain, sensory loss).</li>
            </ul>
            <div class="red-flag-alert" style="margin-top: 1rem; font-size: 0.9rem;">
                <i class="fas fa-exclamation-triangle"></i> Do not initiate other drugs (e.g., Gabapentin) in primary care without specialist advice.
            </div>
        </div>
    </section>

    <!-- SECTION 4: SAFETY & PRESCRIBING -->
    <section class="warning-zone">
        <div class="card warning-zone" style="border-left-color: var(--color-warning);">
            <div class="card-header">
                <i class="fas fa-shield-virus"></i>
                <h2>Carbamazepine Safety</h2>
            </div>

            <!-- Contraindications -->
            <div style="margin-bottom: 1.5rem;">
                <h3 style="color: var(--color-danger); margin-bottom: 0.5rem; font-size: 1rem;">
                    <i class="fas fa-ban"></i> DO NOT PRESCRIBE (Contraindications)
                </h3>
                <div style="background: #ffebee; padding: 10px; border-radius: 4px; font-size: 0.9rem;">
                    <ul style="margin-left: 1.2rem;">
                        <li>Hypersensitivity to carbamazepine or tricyclics.</li>
                        <li>Atrioventricular block.</li>
                        <li>History of bone marrow depression.</li>
                        <li>Hepatic porphyrias.</li>
                        <li>Taking MAOIs (or within 2 weeks of stopping).</li>
                    </ul>
                </div>
            </div>

            <!-- Adverse Effects Toggle -->
            <div>
                <h3 style="color: var(--color-warning); margin-bottom: 0.5rem; font-size: 1rem;">
                    <i class="fas fa-exclamation-triangle"></i> Adverse Effects & Monitoring
                </h3>
                <p class="details-toggle" onclick="toggleDetails('safety-details')">
                    Show Safety Warnings & Interactions <i class="fas fa-chevron-down"></i>
                </p>
                
                <div id="safety-details" class="collapsible-content">
                    <div class="safety-grid">
                        <div class="safety-item" style="border-left: 3px solid #d32f2f;">
                            <strong>Hyponatraemia (20%)</strong><br>
                            Check if dizziness, confusion, or seizures occur. Reduce dose or stop.
                        </div>
                        <div class="safety-item" style="border-left: 3px solid #d32f2f;">
                            <strong>Dermatological (SJS)</strong><br>
                            <strong>HLA-B*1502 Screening:</strong> Mandatory for Han Chinese, HK Chinese, Thai origin. Consider for Malaysia/Philippines.
                        </div>
                        <div class="safety-item">
                            <strong>Blood Disorders</strong><br>
                            Leucopenia (very common). Advise patient to report fever, sore throat, bruising immediately.
                        </div>
                        <div class="safety-item">
                            <strong>Suicidal Thoughts</strong><br>
                            Small risk. Monitor for mood changes.
                        </div>
                    </div>
                    
                    <div style="margin-top: 1rem; background: #e3f2fd; padding: 10px; border-radius: 4px;">
                        <strong><i class="fas fa-pills"></i> Key Interactions:</strong>
                        <ul style="margin-left: 1.2rem; margin-top: 5px; font-size: 0.9rem;">
                            <li>Avoid Diuretics (risk of hyponatraemia).</li>
                            <li>Increased toxicity with: Acetazolamide, Fluoxetine/Fluvoxamine, Azole antifungals, HIV protease inhibitors.</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- Disclaimer Footer -->
    <footer class="full-width" style="text-align: center; margin-top: 2rem; color: var(--color-text-muted); font-size: 0.8rem;">
        <p>Source: NICE CKS Trigeminal Neuralgia (Last revised Jan 2024).</p>
        <p>This tool is for clinical reference only. Always use professional clinical judgement.</p>
    </footer>

</main>

<script>
    // Simple script to handle collapsible sections
    function toggleDetails(id) {
        const content = document.getElementById(id);
        const icon = content.previousElementSibling.querySelector('i');
        
        if (content.classList.contains('active')) {
            content.classList.remove('active');
            icon.classList.remove('fa-chevron-up');
            icon.classList.add('fa-chevron-down');
        } else {
            content.classList.add('active');
            icon.classList.remove('fa-chevron-down');
            icon.classList.add('fa-chevron-up');
        }
    }
</script>

</body>
</html>